National Institutes of Health to Grant Exclusive License for Adult Human Dental Pulp Stem Cells

Summary

The National Institutes of Health (NIH) is considering granting an exclusive license to Angioblast Systems, Inc. to use adult human dental pulp stem cells, postnatal stem cells, and multipotent postnatal stem cells from human periodontal ligament for therapeutic purposes, such as regenerating lost periodontal ligament tissue or repairing dentin/pulp complex damaged during deep caries.